期刊
MICROBES AND INFECTION
卷 7, 期 5-6, 页码 922-931出版社
ELSEVIER
DOI: 10.1016/j.micinf.2005.03.011
关键词
vaccine; tuberculosis; adjuvant; antigen
A tuberculosis (TB) vaccine candidate, Mtb72, was developed following an antigen discovery program involving a combination of expression cloning strategies and evaluation of human immune responses. Adjuvant selection was also performed, resulting in the prioritization of AS02A and AS01B, and an industrial process for vaccine production was developed. Safety, immunogenicity, and protection studies in mice, guinea pigs, rabbits, and monkeys supported the initiation of clinical development of Mtb72f in AS02A. (c) 2005 Elsevier SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据